# FDA recall D-951-2014

> **Aidapak Services, LLC** · Class II · drug recall initiated 2013-07-02.

## Product

hydrOXYzine PAMOATE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00555032402.

## Reason for recall

Labeling: Label Mixup: hydrOXYzine PAMOATE, Capsule, 100 mg may have potentially been mislabeled as one of the following drugs:   CALCIUM CITRATE, Tablet, 950 mg (200 mg Elemental Calcium), NDC 00904506260, AD46257_43, EXP: 5/15/2014;  guaiFENesin ER, Tablet, 600 mg, NDC 45802049878, Pedigree: W002734, EXP: 6/6/2014;  guaiFENesin ER, Tablet, 600 mg, NDC 45802049878, Pedigree: W003689, EXP: 6/26/20

## Distribution

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

## Key facts

- **Recall number:** D-951-2014
- **Recalling firm:** Aidapak Services, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-07-02
- **Report date:** 2014-01-29
- **Termination date:** 2014-02-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Vancouver, WA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-951-2014

## Citation

> AI Analytics. FDA recall D-951-2014. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-951-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*